PHARMACOKINETICS OF KETOROLAC AND P-HYDROXYKETOROLAC FOLLOWING ORAL AND INTRAMUSCULAR ADMINISTRATION OF KETOROLAC TROMETHAMINE

被引：37

作者：

JUNG, D

MROSZCZAK, EJ

WU, A

LING, TL

SEVELIUS, H

BYNUM, L

机构：

来源：

PHARMACEUTICAL RESEARCH | 1989年 / 6卷 / 01期

关键词：

D O I：

10.1023/A:1015803803650

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

引用

收藏

页码：62 / 65

页数：4

相关论文

共 15 条

[1] BLOOMFIELD SS, 1984, CLIN PHARMACOL THER, V35, P228
[2] BROWN CR, 1988, CLIN PHARMACOL THER, V43, P142
[3] HILLIER K, 1981, Drugs of the Future, V6, P669
[4] JUNG DW, UNPUB
[5] Miller R., 1981, SIMULTANEOUS STATIST
[6] MROSZCZAK EJ, 1985, CLIN PHARMACOL THER, V37, P215
[7] MROSZCZAK EJ, 1987, DRUG METAB DISPOS, V15, P618
[8] MUCHOWSKI JM, 1982, J MED CHEM, V28, P1037
[9] THE ANALGESIC AND ANTI-INFLAMMATORY PROFILE OF (+/-)-5-BENZOYL-1,2-DIHYDRO-3H-PYRROLO[1,2A]PYRROLE-1-CARBOXYLIC ACID (RS-37619)
ROOKS, WH
TOMOLONIS, AJ
MALONEY, PJ
WALLACH, MB
SCHULER, ME
[J]. AGENTS AND ACTIONS, 1982, 12 (5-6): : 684 - 690
[10] ROOKS WH, 1985, DRUG EXP CLIN RES, V11, P479